3-D-printed prosthetic implants could improve treatment for hearing loss
Using CT scans and 3-D printing researchers have created accurate, custom-designed prosthetic replacements for damaged parts of the middle ear...
List view / Grid view
Using CT scans and 3-D printing researchers have created accurate, custom-designed prosthetic replacements for damaged parts of the middle ear...
Researchers at NYU Langone Health's Perlmutter Cancer Center report that at least three kinds of bacteria in the mouths of Americans may directly affect their risk of developing oesophageal cancer.
People who inherit genetic changes that alter the function of their immune system are at increased risk of developing Hodgkin lymphoma, according to new study by Institute of Cancer Research.
The EMA has accepted a variation to the MAAv for Tagrisso, for the 1st-line treatment of adult patients with locally advanced or metastatic non-small cell lung cancer...
A blood test to monitor a nerve protein in the blood of people with multiple sclerosis may help predict whether disease activity is flaring up...
A drug that spurs cancer cells to self-destruct has been cleared for use in a clinical trial of patients with anaplastic astrocytoma...
Following new Fraser of Allander Institute analysis, the new Director of ABPI Scotland has called upon the Scottish Government to continue to support and prioritise strategic investments in Scotland’s research, development and manufacturing capabilities...
Researchers have developed tiny drug-laden nanoparticles that can seek and destroy cancer stem cells...
Novartis has announced positive results from the FLASH study examining the safety and efficacy of directly switching COPD patients from Seretide to Ultibro Breezhaler...
An immunotherapy drug can be used to cure a rare type of cancer arising from pregnancy when existing treatments have failed...
Researchers have discovered that a virus-like particle vaccine can prime the body's immune response and prevent the severe respiratory diseases...
Chloroquine and hydroxychloroquine could make cancer treatments more effective...
Glatiramer acetate, a drug used to treat multiple sclerosis, has been found to have an effect on drug-resistant bacteria...
The Chief Executive of the Association of the British Pharmaceutical Industry (ABPI), Mike Thompson responds to the UK’s Budget announcement...
The EC has granted approval to broaden the existing marketing authorisation for Zytiga to include early stage metastatic prostate cancer...